Abbott's humira has new use
LIBERTYVILLE TOWNSHIP -- Abbott Laboratories' top-selling drug, humira, won U.S. approval to treat juvenile rheumatoid arthritis. This is the sixth use for humira approved by the Food and Drug Administration, and the second this year, the Libertyville Township-based company said Friday in a statement. Juvenile rheumatoid arthritis, also known as juvenile idiopathic arthritis, affects about one in 1,000 children, according to Cincinnati Children's Hospital.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.